Core Points - The European Union has launched the "ResourceEU" plan aimed at critical raw materials, focusing on recycling, joint procurement, strategic reserves, and investment to reduce dependence on China while avoiding further tensions in EU-China relations [1][3][6] - The urgency of the plan reflects the EU's recognition of its vulnerabilities in the critical minerals sector, where it heavily relies on imports from Africa and South America, as well as processing from China [6][20] - The plan is a response to the global competition for key minerals essential for technologies like electric vehicle batteries and semiconductors, which are crucial for future industrial dominance [5][8] Industry Insights - The EU's dependence on China is stark, with over 60% of the global market share in refining critical minerals like rare earths, lithium, and cobalt held by China, and some minerals exceeding 80% [20][21] - The "ResourceEU" plan emphasizes the need for supply chain security, which is a core interest for any economic entity, but the transition to a more self-sufficient supply chain is complex and time-consuming [23] - The EU's proposed "anti-coercion instrument" is seen as a significant economic deterrent, but its actual implementation could lead to substantial losses for European industries that are closely tied to the Chinese market [12][18] Strategic Considerations - The EU's strategy includes enhancing recycling capabilities, which currently face technological and scale limitations, making rapid implementation challenging [23] - The "anti-coercion instrument" is a collective action plan that aims to strengthen the EU's bargaining power in international trade, leveraging its large internal market [16][14] - The EU's approach reflects a balancing act between asserting its economic independence and maintaining cooperative relations with China, as both sides have intertwined interests in the critical minerals sector [25]

（文章来源：证券日报） 证券日报网12月5日讯菲利华在12月5日回答调研者提问时表示，目前公司高纯石英砂一期10000吨产能 已全部建成，可应用于光伏和光通讯等领域。同时，公司也在研发高纯合成石英砂，目前项目已转入中 试阶段，有利于推进公司自有完整的产业链建设，保障供应链安全。公司在半导体领域主要的客户为下 游石英器件加工商。 ...

Core Insights - Apple has decided to adopt Intel's 18A (1.8nm) process technology for its next-generation low-end MacBook and other Mac devices, marking a strategic shift in its advanced manufacturing choices [1][2] - This decision indicates Apple's intention to avoid reliance on Samsung's foundry, which currently has 2nm production capabilities, due to concerns over supply chain security [2][3] Group 1 - Intel is expected to start delivering chips based on the 18A process to Apple by mid-2027, with these chips likely to be part of the M6 or M7 series [2][3] - The new chips will be used in future product lines including MacBook Air, iPad Air, and iPad Pro, contributing to Apple's localized supply chain strategy [2][3] Group 2 - Samsung's dual role as a competitor in key markets such as smartphones, tablets, laptops, smartwatches, and XR devices has led Apple to exercise caution in its supply chain decisions [3]

Core Viewpoint - The semiconductor supply chain crisis, triggered by a power struggle within a Chinese-controlled semiconductor company, has led to significant production disruptions for major automotive manufacturers like Volkswagen, BMW, and Ford, highlighting the vulnerability of global supply chains to geopolitical interventions [2][3][4]. Summary by Sections 1. Event Overview - The crisis began with a governance dispute at Nexperia (安世半导体), a semiconductor company acquired by a Chinese consortium in 2017, which has become a key supplier for the automotive industry [3][4]. - The U.S. imposed new export controls in September 2025, leading to the Dutch government freezing Nexperia's global assets under the pretext of national security, which resulted in a near collapse of the global automotive chip supply chain [5][6]. 2. Impact on Automotive Industry - Major automakers, including Volkswagen, BMW, and Honda, issued production warnings, with the European Automobile Manufacturers Association predicting a potential 15% reduction in European automotive production capacity within weeks if the supply issue is not resolved [7][8]. - The automotive industry relies heavily on specific components produced by Nexperia, and the lack of these components could halt production lines, as seen with Volkswagen reporting its first quarterly loss in five years [6][7]. 3. Geopolitical Context - The incident illustrates the intersection of geopolitics and high-tech industries, revealing the fragility of global supply chains under political pressure [3][9]. - The U.S. strategy to curb China's technological advancements has been implemented through European allies, as evidenced by the timing of the Dutch government's actions following U.S. directives [9][10]. 4. Corporate Governance Issues - The governance conflict within Nexperia escalated when the Dutch court intervened, leading to the removal of the Chinese CEO and the appointment of a temporary Dutch CEO, which was perceived as a politically motivated takeover [5][6]. - The internal governance issues at Nexperia, including differing strategic priorities between Chinese and European management, contributed to the crisis [11][12]. 5. Future Implications - The semiconductor crisis signals a shift in the global semiconductor landscape from an "efficiency-first" model to a "security-first" approach, prompting companies to reassess their supply chain strategies [15][16]. - The event serves as a wake-up call for Chinese companies regarding the importance of political risk assessment and the need for a more resilient and localized supply chain strategy [15][19].

Group 1 - The core viewpoint of the news is that the restructuring plan for Shanshan Group, led by Jiangsu "Ship King" Ren Yuanlin, was rejected by creditors and investors, prompting the company to seek new investors [1] - Fangda Carbon, a leading company in the carbon industry, announced its intention to participate in the substantive merger and restructuring of Shanshan Group and its subsidiary Pengze Trading [1] - Fangda Carbon's main products include graphite electrodes and other carbon materials, which align well with Shanshan Group's focus on lithium battery anode materials and LCD polarizers [1] Group 2 - Fangda Carbon's major shareholder is Liaoning Fangda Group, controlled by Fang Wei, who is currently the richest person in Liaoning with a net worth of 52.5 billion yuan [2] - In 2021, Fangda Group successfully restructured HNA Group for a consideration of 41 billion yuan, gaining control over HNA Holdings [2] - Fang Wei currently controls five listed companies, including Fangda Carbon and HNA Holdings, indicating a strong presence in the market [2]

Core Viewpoint - The ongoing trade war has highlighted the United States' dependency on China for critical resources, particularly in the rare earth and pharmaceutical sectors [1][3][4]. Group 1: Rare Earth Industry - A rare earth processing center in South Carolina has successfully produced its first domestic rare earth magnet, which has been interpreted by the media as a sign of a manufacturing revival in the U.S. [1] - Despite this achievement, the U.S. remains heavily reliant on China for both rare earth materials and pharmaceutical raw materials [1]. Group 2: Pharmaceutical Supply Chain - The pharmaceutical supply chain is identified as a crucial leverage point for China in U.S.-China negotiations, with China holding a dominant position in the global pharmaceutical market [3]. - As of the latest data, China accounts for 45% of global drug ingredient registrations, significantly outpacing India's 19% [3]. - China is the sole supplier of approximately 700 key drug core chemical components, indicating its deep integration into the global healthcare system [3]. Group 3: U.S. Political Response - U.S. political figures have reacted strongly, with calls for collaboration with allies like India to establish alternative supply chains to reduce dependency on China [4]. - The U.S. has previously imposed high tariffs on medical equipment and patented drugs from China, which could increase healthcare costs for American citizens [4]. Group 4: Innovation in Chinese Pharmaceutical Industry - China's pharmaceutical industry has transitioned from follower innovation to original innovation, enhancing its influence in new drug development and clinical trials [6]. - Efforts to decouple from China's pharmaceutical supply chain are deemed increasingly unrealistic, as even India, the largest generic drug producer, relies on Chinese raw materials [6]. - The globalized nature of supply chains makes it nearly impossible for the U.S. to achieve supply chain security through protectionist measures [6].

Core Viewpoint - Critical Raw Materials (CRMs) are essential for European defense, particularly for advanced military equipment, yet Europe heavily relies on imports, especially from China, creating supply chain vulnerabilities that threaten defense autonomy and security [1][2]. Group 1: Supply Chain Vulnerabilities - Europe is increasingly dependent on imports of CRMs, particularly from China, which poses risks to its defense capabilities and strategic autonomy [1][2]. - The geopolitical tensions and the urgent need for technological modernization have heightened concerns regarding the security and sufficiency of critical materials [1][2]. - The COVID-19 pandemic has underscored the potential impacts of supply chain disruptions on critical industries, exacerbating existing vulnerabilities [2]. Group 2: Government Responses - Governments are adopting diverse strategies to mitigate supply chain risks, including diversifying supply sources, stockpiling materials, and enhancing domestic production capabilities [3][10]. - The European Union's Critical Raw Materials Act aims to identify and manage dependencies on strategic materials, ensuring supply chain stability and promoting sustainable economic development [11][12]. - Legislative measures are increasingly incorporating clauses related to the security of critical materials supply, reflecting a growing political focus on this issue [3][10]. Group 3: Strategic Partnerships and Initiatives - Countries are seeking to establish new strategic partnerships and strengthen existing ones to enhance resource security, a strategy referred to as "raw materials diplomacy" [12][13]. - The EU has initiated strategic cooperation with countries like Kazakhstan and Greenland to mitigate supply risks for critical materials such as titanium [12]. - The establishment of a temporary reserve strategy by the EU is being considered to bolster supply chain resilience, although legislative attention on defense issues remains less comprehensive compared to the U.S. [12][13]. Group 4: Challenges in Material Management - The process of reshoring critical materials extraction and processing faces challenges, including higher production pressures and stricter environmental regulations [13]. - The unique properties of certain materials complicate substitution efforts, and recycling remains a developing field with cost implications [4][10]. - The interplay between defense needs and energy transition initiatives may yield beneficial synergies, as many critical materials are common to both sectors [4].

美国与中国之间的贸易战，如今又多了一项新景象：药品供应链的"暗战"。这条看似不为人知的供应链，不仅是关乎国民健康的生命线，更是两国战略角力 中的一个重要筹码。 根据最新的数据，中国在药物成分备案中占据了45%的市场份额，远超印度的19%。这一趋势并非偶然，而是经过数十年的发展，中国的制药工业已经完成 了从"跟随式创新"到"首创式创新"的华丽转身。这意味着，中国不仅在制造上占据优势，甚至在新药研发及临床试验方面都具备了强大的话语权。 美方智库已然意识到，试图与中国"脱钩"的想法显得不切实际。在追求供应链安全的同时，美国却需要特别警惕"恶人先告状"的现实。所谓的替代方案，比 如与印度合作，严重依赖中国资源的现状并没有得到根本改善。这样的供应链布局，注定不会容易破解。 面对这一复杂的局势，中国并没有简单地将药品视为一枚可利用的棋子，反而表现出了高度的责任感。官方多次强调，药品关乎人类健康，绝不应成为地缘 政治的工具。而在稀土出口时，中国还特别设立了人道主义豁免条款。这一系列做法，无疑显示出中国在全球医疗和制药领域的建设性作用，以及希望维护 供应链稳定的决心。 值得注意的是，中国作为近700种关键药物核心化学成分的唯 ...

Core Viewpoint - Fangda Carbon New Material Technology Co., Ltd. plans to participate in the substantive merger and restructuring of Shanshan Group and its wholly-owned subsidiary, Ningbo Pengze Trading Co., Ltd. [3][4] Group 1: Company Actions - On November 24, Fangda Carbon held a board meeting and approved the proposal to participate as an industrial synergy partner in the restructuring of Shanshan Group and Ningbo Pengze [3] - The company will prepare and submit the necessary documentation for the restructuring investment, including a due diligence confidentiality agreement and a restructuring investment plan [3][4] - The participation in the restructuring does not constitute a related party transaction or a major asset reorganization, thus does not require shareholder meeting approval [4] Group 2: Strategic Implications - Fangda Carbon aims to leverage its advantages in the anode industry to enhance its industrial chain integration and supply chain stability through this restructuring [4] - The company anticipates that this move will positively impact its future operational development and enhance its core competitiveness [4] Group 3: Context of Restructuring - Shanshan Group and Ningbo Pengze have initiated a new round of restructuring, with the process involving initial selection, final selection, and creditor committee voting [4] - A recent creditors' meeting revealed that the restructuring plan was not approved, indicating challenges in the ongoing restructuring efforts [5][6]

记者丨赵云帆 编辑丨朱益民 11月24日晚间，"方大系"旗下方大炭素（600516.SH）公告，同意公司作为产业协同方参与杉杉集团有 限公司及其全资子公司宁波朋泽贸易有限公司的实质合并重整投资人招募，同时授权公司管理层代表公 司拟定和提交重整投资的报名资料、签署尽职调查保密协议、开展尽职调查、提交《重整投资方案》等 各项工作。 疑似受到消息驱动，方大炭素11月25日收盘以涨停报收，报6.51元/股；杉杉集团旗下杉杉股份 （600884.SH）收涨5.74%。 另据21世纪经济报道获悉，目前杉杉集团及宁波朋泽已经开启新一轮重组，流程仍将按照初选，终选， 以及债权人委员会投票的方式决定。 继杉杉集团首次重组草案意外流产之后，重整计划的新重整投资人遴选已经悄然开始。第一个选择广而 告之的意向投资者，为长袖善舞的"方大系"。 "上周宁波方面组织召开了一个意向投资者的沟通会，方大炭素位列其中。"有接近重组的知情人士告诉 21世纪经济报道记者："其中方大炭素不是早一届遴选的意向投资者，而是这轮遴选的全新参与方。" 该人士还向记者透露，新一轮遴选参与的投资者有先前的一些投资者，也有像方大炭素一样的新意向投 资者，还有部分过 ...